Results 21 to 30 of about 810,489 (200)

Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia

Diagnostic Microbiology and Infectious Disease, 2021
Carbapenem-resistant Enterobacterales (CRE) are classified as either carbapenemase-producing CRE (CP-CRE) or non-carbapenemase-producing CRE (non-CP-CRE) based on their mechanism of carbapenem resistance. Few studies have compared outcomes associated with each type of infection.
Michael R, Hovan, Navaneeth, Narayanan, Vanessa, Cedarbaum, Tanaya, Bhowmick, Thomas J, Kirn   +4 more
openaire   +5 more sources

Carbapenem-resistant Enterobacterales—Kentucky, 2013–2020

Journal of Appalachian health, 2023
Introduction: Carbapenem-resistant Enterobacterales (CRE) are considered urgent, antibiotic-resistant threats in the U.S. and are of global concern. Active collaboration between public health authorities and healthcare facilities and providers will be necessary to prevent and contain these organisms.
Issac, Mary, Flinchum, Andrea, Spicer, Kevin   +2 more
openaire   +2 more sources

Carbapenem-Resistant Enterobacterales Infections and Their Association with Rectal Colonization

Konuralp Tıp Dergisi, 2023
Objectives: Carbapenem-resistant Enterobacterales (CRE) infections have limited treatment options, and these infections are associated with high mortality rates. Asymptomatic carriers colonized with CRE contribute to the spread of CRE in hospitals. It was aimed to determine the frequency of CRE isolates detected in our center, carbapenemase ratios in ...
Aydemir, Ozlem, Koroglu, Mehmet, Ormanoglu, Gokcen, Ayhanci, Tugba, Aydemir, Yusuf, Guclu, Ertugrul, Köroğlu, Mehmet, Aydemir, Yusuf   +7 more
openaire   +2 more sources

Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018 [PDF]

Antimicrobial Resistance & Infection Control, 2021
Abstract Background Carbapenem-resistant Enterobacterales (CRE) is a global threat. Enterobacterales develops carbapenem resistance through several mechanisms, including the production of carbapenemases. We aim to describe the prevalence of Carbapenem-resistant Enterobacterales (CRE) with and without carbapenemase ...
Wantana Paveenkittiporn, Meghan Lyman, Caitlin Biedron, Nora Chea, Charatdao Bunthi, Amy Kolwaite, Noppavan Janejai   +6 more
openaire   +3 more sources

A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques

Microorganisms, 2023
Infectious disease outbreaks have caused thousands of deaths and hospitalizations, along with severe negative global economic impacts. Among these, infections caused by antimicrobial-resistant microorganisms are a major growing concern. The misuse and overuse of antimicrobials have resulted in the emergence of antimicrobial resistance (AMR) worldwide ...
Oznur Caliskan-Aydogan, Evangelyn C. Alocilja   +1 more
openaire   +3 more sources

An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales

Medicina, 2022
Improper use of antimicrobials has resulted in the emergence of antimicrobial resistance (AMR), including multi-drug resistance (MDR) among bacteria. Recently, a sudden increase in Carbapenem-resistant Enterobacterales (CRE) has been observed. This presents a substantial challenge in the treatment of CRE-infected individuals. Bacterial plasmids include
Ali A. Rabaan, Khalid Eljaaly, Saad Alhumaid, Hawra Albayat, Wasl Al-Adsani, Amal A. Sabour, Maha A. Alshiekheid, Jumana M. Al-Jishi, Faryal Khamis, Sara Alwarthan, Mashael Alhajri, Amal H. Alfaraj, Huseyin Tombuloglu, Mohammed Garout, Duaa M. Alabdullah, Elmoeiz Ali Elnagi Mohammed, Fatimah S. Al Yami, Haifa A. Almuhtaresh, Kovy Arteaga Livias, Abbas Al Mutair, Shawqi A. Almushrif, Mai Abdel Haleem A. Abusalah, Naveed Ahmed   +22 more
openaire   +4 more sources

Carbapenem-resistant enterobacterales, carbapenem resistant organisms, carbapenemase-producing enterobacterales, and carbapenemase-producing organisms:Terminology past its 'sell-by-date' in an era of new antibiotics and regional carbapenemase epidemiology [PDF]

, 2020
Carbapenem resistance in Gram-negative bacteria is a public health concern. Consequently, numerous government and agency reports discuss carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant organisms (CROs). Unfortunately, these terms are
Livermore, David M., Nicolau, David P., Hopkins, Katie L., Meunier, Danièle   +3 more
core   +1 more source

Tree diagram for carbapenem-resistant Enterobacterales infections.

, 2022
Tree diagram for carbapenem-resistant Enterobacterales infections.
Nicholas Graves (258283), David Lye (336978), Winnie Lee (328670), Grace S. R. Hoo (14232128), Andrea L. Kwa (8964998), Joanne Yoong (228710), Yiying Cai (328668), Ban Hock Tan (7507319), Yik-Ying Teo (159446)   +8 more
core   +1 more source

Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar [PDF]

European Journal of Clinical Microbiology & Infectious Diseases, 2021
AbstractOne hundred forty-nine carbapenem-resistant Enterobacterales from clinical samples obtained between April 2014 and November 2017 were subjected to whole genome sequencing and multi-locus sequence typing. Klebsiella pneumoniae (81, 54.4%) and Escherichia coli (38, 25.5%) were the most common species.
Abid, Fatma Ben, Tsui, Clement K. M., Doi, Yohei, Deshmukh, Anand, McElheny, Christi L., Bachman, William C., Fowler, Erin L., Albishawi, Ahmed, Mushtaq, Kamran, Ibrahim, Emad B., Doiphode, Sanjay H., Hamed, Manal M., Almaslmani, Muna A., Alkhal, Abdullatif, Butt, Adeel A., Omrani, Ali S.   +15 more
openaire   +2 more sources

Correlation between Mechanism of Carbapenem Resistance and in vitro Efficacy of Ceftazidime-Avibactam and Meropenem-Vaborbactam on Carbapenem-Resistant Enterobacterales and Pseudomonas Aeruginosa

Pakistan Armed Forces Medical Journal, 2022
Objective: To determine the mechanism of Carbapenem resistance, type of Carbapenemase produced and in vitro efficacy of Ceftazidime-Avibactam (CAZ-AVI) and Meropenem-Vaborbactam (MEV) against Carbapenem-resistant Enterobacterales and in vitro efficacy ...
Fatima Ali, Irfan Ali Mirza, Hafsa Waseem, Umer Khursheed, Humaira Zafar, Maryiam Sarwar   +5 more
doaj   +1 more source